Test Price
2,800 AEDโ Home Collection Available
PITX3 Gene Anterior Segment Mesenchymal Dysgenesis (ASMD) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Overview
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Certified Next-Generation Sequencing (NGS) processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Genetic Counseling included in the service.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test analyzes the PITX3 gene using high-coverage Next-Generation Sequencing (NGS) to identify pathogenic variants responsible for anterior segment mesenchymal dysgenesis (ASMD) and related congenital eye anomalies. The test provides definitive molecular diagnosis, enabling precise clinical management and family risk assessment.
| Parameter | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% sensitivity, full gene coverage | ~95% for targeted regions; may miss deep intronic variants |
| Methodology | NGS Technology (Illumina, 1000x coverage) | Capillary Sanger Sequencing |
| TAT | 3 to 4 Weeks | 4 to 6 Weeks |
| ICD-10 / LOINC | Q13.8, Q15.0, Q13.4 / LOINC 21634-7 | Q13.8 / LOINC 21634-7 |
Physician Insight & Safety Protocols
Insight from Consultant Medical Genetics:
โIdentification of a pathogenic PITX3 variant confirms the molecular basis of anterior segment dysgenesis. However, clinical correlation with ophthalmic findings is essential for accurate prognosis and family counseling. This NGS-based test offers high sensitivity and supports early intervention strategies.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ ๏ธ Medication Advisory
Do not alter or discontinue prescribed treatments based solely on genetic test results. Any therapeutic changes must be supervised by your ophthalmologist or genetic specialist.
Patient Safety: Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not suitable for individuals with a history of recent blood transfusion (within 2 weeks) as it may affect DNA quality.
- Exclusion: Neonates weighing below 1 kg may require special sample collection โ consult our genetic counselor.
- Seek Immediate Medical Care if you experience: Sudden vision loss, severe eye pain, extreme light sensitivity, or halos around lights.
Patient FAQ & Clinical Guidance
1. What is the PITX3 genetic test used for?
The PITX3 gene NGS test definitively identifies pathogenic mutations causing anterior segment dysgenesis, enabling accurate diagnosis, prognosis, and inheritance risk assessment for affected individuals and their families.
2. How is the sample collected and what is the turnaround time?
A simple blood draw is collected at your convenience by our VIP Mobile Phlebotomy team (available 8 AMโ11 PM, daily). Results are delivered within 3โ4 weeks along with telephonic genetic counseling to discuss findings and next steps.
3. Is this genetic test covered by insurance in the UAE?
Many UAE health insurance plans now cover genetic testing for congenital eye anomalies. We offer direct billing verification via WhatsApp at +971 54 548 8731 prior to your appointment to confirm coverage.
4. Can this test be performed on a newborn or child?
Yes, genetic testing for congenital eye conditions is safe for all ages. For neonates under 1 kg, please consult our genetic counselor to arrange appropriate sample collection.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
- Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety and patient consent governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- All genetic data is stored securely with restricted access and encrypted transmission.
Clinical & Logistical Metadata
| Test Name | PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) โ Illumina 1000x coverage |
| ICD-10-CM Code | Q13.8, Q15.0, Q13.4 |
| LOINC Code | 21634-7 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians